446 related articles for article (PubMed ID: 29212306)
1. Oncogene-Driven Metabolic Alterations in Cancer.
Min HY; Lee HY
Biomol Ther (Seoul); 2018 Jan; 26(1):45-56. PubMed ID: 29212306
[TBL] [Abstract][Full Text] [Related]
2. Targeting metabolic reprogramming in KRAS-driven cancers.
Kawada K; Toda K; Sakai Y
Int J Clin Oncol; 2017 Aug; 22(4):651-659. PubMed ID: 28647837
[TBL] [Abstract][Full Text] [Related]
3. KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer.
Pupo E; Avanzato D; Middonti E; Bussolino F; Lanzetti L
Front Oncol; 2019; 9():848. PubMed ID: 31544066
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic
Zhang L
Glob Med Genet; 2020 Jun; 7(1):1-2. PubMed ID: 32879916
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect.
Sun L; Suo C; Li ST; Zhang H; Gao P
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):51-66. PubMed ID: 29959989
[TBL] [Abstract][Full Text] [Related]
6. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
Lv J; Wang J; Chang S; Liu M; Pang X
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):17-26. PubMed ID: 26487443
[TBL] [Abstract][Full Text] [Related]
7. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
Vaupel P; Schmidberger H; Mayer A
Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells.
Sreedhar A; Zhao Y
Biomed Rep; 2018 Jan; 8(1):3-10. PubMed ID: 29399334
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
Li C; Zhang G; Zhao L; Ma Z; Chen H
World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
[TBL] [Abstract][Full Text] [Related]
10. MYC Rules: Leading Glutamine Metabolism toward a Distinct Cancer Cell Phenotype.
Tambay V; Raymond VA; Bilodeau M
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503295
[TBL] [Abstract][Full Text] [Related]
11. Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways.
Fumarola C; Petronini PG; Alfieri R
Biochem Pharmacol; 2018 May; 151():114-125. PubMed ID: 29530507
[TBL] [Abstract][Full Text] [Related]
12. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.
Pal S; Sharma A; Mathew SP; Jaganathan BG
Front Immunol; 2022; 13():955476. PubMed ID: 36618350
[TBL] [Abstract][Full Text] [Related]
13. PCK1 dysregulation in cancer: Metabolic reprogramming, oncogenic activation, and therapeutic opportunities.
Xiang J; Wang K; Tang N
Genes Dis; 2023 Jan; 10(1):101-112. PubMed ID: 37013052
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Metabolic Reprogramming by Long Non-Coding RNAs in Cancer.
Sellitto A; Pecoraro G; Giurato G; Nassa G; Rizzo F; Saggese P; Martinez CA; Scafoglio C; Tarallo R
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298698
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Hallmarks of Cancer Metabolism.
Pavlova NN; Thompson CB
Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
[TBL] [Abstract][Full Text] [Related]
16. Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics.
Cha JY; Lee HJ
J Cancer Prev; 2016 Dec; 21(4):209-215. PubMed ID: 28053954
[TBL] [Abstract][Full Text] [Related]
17. Lipid metabolism in cancer progression and therapeutic strategies.
Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
[TBL] [Abstract][Full Text] [Related]
18. Signaling Pathways Regulating Redox Balance in Cancer Metabolism.
De Santis MC; Porporato PE; Martini M; Morandi A
Front Oncol; 2018; 8():126. PubMed ID: 29740540
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies.
Xu R; Yang J; Ren B; Wang H; Yang G; Chen Y; You L; Zhao Y
Front Oncol; 2020; 10():572722. PubMed ID: 33117704
[TBL] [Abstract][Full Text] [Related]
20. Metabolic rewiring directs melanoma immunology.
Sun N; Tian Y; Chen Y; Guo W; Li C
Front Immunol; 2022; 13():909580. PubMed ID: 36003368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
